Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Johnson & Johnson实时行情
The current price of Johnson & Johnson in the market is ¥1,286.37, with a 24-hour trading volume of ¥2.37B. The asset's market cap is ¥3.09T, after moving 0.54% in the last day.